Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
· financialcontent
AI Briefing
- Theralase(R) Reports Positive Results from Preclinical Study
- X-Ray-Activated Rutherrin(R) Shows Potential to Treat Muscle Invasive Bladder Cancer
- Company to Pursue Regulatory Approvals for Potential New Cancer Therapy
Advertisement